Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scout Bio
Philadelphia, Pennsylvania, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Scout Bio's gene therapy platform has shown durable therapeutic protein expression and clinical benefit in veterinary patients, including statistically significant hematocrit improvement in feline CKD-associated anemia (SB-001). Early pilot studies also indicate potential clinical benefit in chronic disease management for pets[6].
- Therapeutic areas
- NephrologyDermatologyEndocrinologyRheumatology
- Modalities
- Gene therapyMonoclonal antibody
- Industry
- Veterinary
02
Partnerships
University of Pennsylvania Gene Therapy Program (GTP)
Beyond the preview
Go deeper on Scout Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scout Bio.